BIOCHEMICAL ASPECTS OF THE PHARMACOLOGY OF MOCLOBEMIDE - THE IMPLICATIONS OF ANIMAL STUDIES

被引:9
作者
CALLINGHAM, BA
机构
关键词
D O I
10.1192/S0007125000297493
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:53 / 60
页数:8
相关论文
共 49 条
[21]  
DAPRADA M, 1989, J PHARMACOL EXP THER, V248, P400
[22]  
DAPRADA M, 1984, MONAOMINE OXIDASE DI
[23]  
DAPRADA M, 1986, ADV NNEUROLOGY, V45
[24]  
DAPRADA M, 1982, MONOAMINE OXIDASE BA
[25]  
DELLACORTE L, 1977, BIOCHEM PHARMACOL, V26, P407
[26]  
DELLACORTE L, 1980, BIOCHEM PHARMACOL, V29, P811
[27]  
Finberg J P, 1988, J Neural Transm Suppl, V26, P11
[28]   TYRAMINE ANTAGONISTIC PROPERTIES OF AGN-1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE TYPE-B [J].
FINBERG, JPM ;
TENNE, M ;
YOUDIM, MBH .
BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (01) :65-74
[29]   RELATIONSHIP BETWEEN TYRAMINE POTENTIATION AND SELECTIVE-INHIBITION OF MONOAMINE-OXIDASE TYPE-A AND TYPE-B IN THE RAT VAS-DEFERENS [J].
FINBERG, JPM ;
TENNE, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1982, 77 (01) :13-21
[30]   MONOAMINE-OXIDASE A AND B - USEFUL CONCEPT [J].
FOWLER, CJ ;
CALLINGHAM, BA ;
MANTLE, TJ ;
TIPTON, KF .
BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) :97-101